|Home||» Products||» Generic Medicines||» Megahenz 160(Megestrol Acetate Tablets Ip)|
Product Name: Megahenz 160
Generic Name: Megestrol Acetate Tablets Ip
Manufacturer : Alniche
Megahenz Tablet is asynthetic form of the naturally occurring hormone progesterone which is mostcommonly used as an appetite stimulating agent in the treatment of anorexia andcachexia associated with HIV/AIDS. It is also used as an antineoplastic agentin the palliate treatment of breastcancer or endometrial cancer.Megahenz isa man-made chemical similar to the female hormone progesterone.
Megahenz is used to treatloss of appetite and weight loss in people with acquired immunodeficiencysyndrome (AIDS). Megahenz is also used in the treatment of advanced breastcancer and endometrial cancer.
Megahenz may also be usedfor purposes not listed in this medication guide.
HOWSHOULD I USE MEGAHENZ?
Use Megahenz as directed by your doctor. Check the label on themedicine for exact dosing instructions.
Â§ Â§ Â§
Each film-coated tabletcontains a small amount of 2 different female hormones, namely levonorgestrel100 mcg and ethinylestradiol 20 mcg. The other ingredients (excipients) areanhydrous lactose, povidone K-30 (E1201), magnesium stearate (E572) and opadryII pink [polyvinyl alcohol, talc (E553b), titanium dioxide (E171), polyethyleneglycol 3350, red aluminum lake (E129), lecithin (E322), iron oxide red (E172)and blue aluminum lake (E1329)].
Megahenz tablets areindicated for use in the palliative treatment of advanced carcinoma of thebreast: 160 mg/day (40 mg of oral tablets four times a day)
Megahenz tablets areindicated for use in the palliative treatment of advanced carcinoma of theendometrium: 40 to 320 mg/day of oral tablets in divided doses
Megahenz oral suspension isindicated for use in the treatment of anorexia at a dose of 800 mg/day.
Alternatively, 625 mg/5 mLof the concentrated formula (Megace ES formula) may be given.
Note: 800 mg/20 mL of theregular formula is equivalent to 625 mg/ 5 mL of the concentrated formula.
The following seriousreactions and otherwise important adverse drug reactions are discussed ingreater detail in other sections of the labeling:
Â§ Â§ Â§ FetalEffects [ ]